About Us

Spotlight Innovation Inc. (OTCQB: STLT) acquires and develops proprietary therapies to address unmet medical needs, with an emphasis on rare, emerging and neglected diseases. The Company identifies in-licensing opportunities and manages product development through partnerships with universities, medical schools, contract research organizations (CROs), and contract manufacturing organizations (CMOs). At the appropriate stage of research and development the Company will endeavor to pursue product commercialization opportunities including, but not limited to, out-licensing and strategic partnerships with industry leaders.


Venodol Roll-on

Venodol Roll-on Topical Analgesic

Venodol Roll-on Topical Analgesic

Caretta Therapeutics, a subsidiary of Spotlight Innovation, has announced that its initial over-the-counter chronic pain relief product, Venodol Roll-on, is available online at venodol.com. Venodol Roll-on topical analgesic is formulated to provide long-lasting relief from chronic pain associated with inflammation, including joint pain, tendinitis, arthritis (excluding osteoarthritis), and stubborn body aches.